General Information of Drug (ID: DMRDEPN)

Drug Name
mRNA-1045
Indication
Disease Entry ICD 11 Status REF
Influenza 1E30-1E32 Phase 1 [1]
Respiratory syncytial virus infection 1C80 Phase 1 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D53KHJ
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT05585632) Phase 1, Randomized, Observer-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Multi-component Vaccines mRNA-1045 (Influenza and RSV) or mRNA-1230 (Influenza, RSV, and SARS-CoV-2) Compared With mRNA-1010 (Influenza), mRNA-1345 (RSV), and mRNA-1273.214 (SARS-CoV-2) Vaccines in Healthy Adults 50-75 Years of Age. U.S.National Institutes of Health.